Skip to main content Accessibility help
×
Home

Surveillance of Hemodialysis-Associated Primary Bloodstream Infections: The Experience of Ten Hospital-Based Centers

  • Margaret Dopirak (a1), Connie Hill (a2), Marylee Oleksiw (a3), Diane Dumigan (a4), Jean Arvai (a5), Ellen English (a6), Evelyn Carusillo (a7), Susan Malo-Schlegel (a1), Jeana Richo (a8), Karen Traficanti (a6), Bobbie Welch (a9) and Brian Cooper (a10)...

Abstract

Objective:

To determine baseline rates of primary bloodstream infection (BSI) among a large pool of patients receiving hemodialysis using standardized surveillance tools and methodology.

Design:

Prospective, descriptive analysis of primary BSI rates.

Setting:

Ten hospital-based hemodialysis centers in Connecticut.

Patients:

All patients receiving long-term hemodialysis in the participating facilities.

Results:

A total of 158 BSIs occurred during 142,525 dialysis sessions within a 12-month study period. Of the BSIs, 15.2% occurred in patients with fistula or graft access and 84.8% in patients with central venous catheter access (P < .001). Rates per 100 patient-years in centers ranged from 0 to 30.8, with a mean of 16.6. Rates per 1,000 dialysis sessions ranged from 0 to 2.1, with a mean of 1.1. Coagulase-negative staphylococci and Staphylococcus aureus (including methicillin-resistant S. aureus) accounted for 61% and Klebsiella or Enterobacter species for 14.6% of infections. Of the patients, 63.3% received vancomycin, 24.7% received cefazolin, and 41.7% received aminoglycosides. Rates declined in the second 6 months of the study from 1.4 to 0.8 infections per 1,000 dialysis sessions (P < .001).

Conclusions:

Primary BSI rates varied widely among participating centers and declined during the study period. BSIs were strongly associated with central venous catheter access. Further studies are needed to determine the reasons for variance in rates between centers and among various types of hemodialysis access.

Copyright

Corresponding author

Middlesex Hospital, 28 Crescent Street, Middletown, CT 06457

References

Hide All
1.U.S. Renal Data System. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 1997;30(2 suppl 1):S160S177.
2.USRDS Coordinating Center. 1999 Annual Data Report. Bethesda, MD: National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1999:9091.
3.Feldman, HI, Held, PJ, Hutchinson, JT, Stoiber, E, Hartigan, MF, Berlin, JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:10911096.
4.Hoen, B, Paul-Dauphin, A, Hestin, D, Kessler, M. EPIBACDIAL: a multi-center prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998;9:869876.
5.Tokars, JI, Miller, ER. National Surveillance of Dialysis-Associated Diseases in the United States, 1996. Atlanta, GA: National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, Department of Health and Human Services; 1996.
6.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128140.
7.Trick, WE, Fridkin, K, Edwards, JR, Gaynes, RP. Trends in primary bloodstream infections associated with Candida spp in the United States. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections; March 5-9, 2000; Atlanta, GA.
8.Weinstein, MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 1996;23: 4046.
9.Keane, WF, Collins, AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24:10101018.
10.Beddhu, S, Bruns, FJ, Saul, M, Seddon, P, Zeidel, ML. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000;108:609613.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed